Experts agree that CROs will be more connected in 2016, however limitations – and hesitatations – still surround remote based monitoring.
Experts: We must embrace cos like Apple and Google to manage new mass of clinical data
Apple and Google needed to make sense of growing clinical data mass, say experts. With data becoming growingly important in clinical trials, CROs and sponsors must embrace companies like Apple and Google to manage it, say panelists at PCT Europe. (Outsourcing-Pharma.com)
Pierre Fabre deploys biosensors to enrich clinical trial data
Researchers at Pierre Fabre have started to use implantable chips as biosensors to improve the data gathered whilst monitoring clinical trial subjects. (Outsourcing-Pharma.com)
FDA seeks comments on mHealth in clinical trials
…In an October 29 notice published in the Federal Register, the FDA is seeking input on how mHealth technology might be used to improve clinical trials. The agency is particularly interested in how healthcare providers and other parties are using consumer-generated data, how they’re reaching out to consumers, and whether the data being collected is useful and reliable. (mHealthNews)
Hearables, Wristables and Eyewearables!
Clearly there’s lots of creativity and innovative products in the wearables market and few signs of slowing down. How do you see wearables influencing clinical trials and healthcare in the future? (Geeks Talk Clinical)
Data-gathering implantable chips to be tested in schizophrenia trial
Although wearables have yet to establish themselves as a mainstream clinical trial technology, some research teams are already looking to the next big thing: implantables. Pierre Fabre has moved itself to the front of the field by striking a deal to test a chip in a schizophrenia development program. (FierceBiotechIT)
Califf seeks new “ecosystem” for clinical trials
www.appliedclinicaltrialsonline.com
Current clinical trials are regarded as “too slow, too expensive, not reliable, and not designed to answer the important questions,” according to FDA’s new deputy commissioner for medical products & tobacco, Robert Califf. (Applied Clinical Trials)
Qualcomm’s Capsule wins FDA nod for patient monitoring system
Qualcomm (NASDAQ:QCOM) medical data management subsidiary capsule Tech said it received 510(k) clearance for its SmartLinx Vitals Plus patient monitoring system. (Massachusetts Device)
Data mining as a path to better trial design
The prospects of Big Data are tantalizing for the life sciences industry, but there’s still much left to do with small data. (Geeks Talk Clinical, Medidata Solutions)
Novartis joint venture helps virtual trial CRO to $6.5 million fundraising round
Science 37 has raised $6.5m (5.7m pounds) from Lux Capital and dRx capital, the fund set up by Novartis and Qualcomm, to advance its virtual clinical trial service business. (Outsourcing-Pharma.com)